NIIT Limited has announced the allotment of 15,000 equity shares under its long-standing Employee Stock Option Plan-2005 (ESOP-2005). The approval for this allotment was granted by the company’s Share Allotment Committee on December 11, 2025, marking another step in NIIT’s ongoing employee incentive and ownership program.
Share Allotment Details
The company outlined key parameters related to the latest allotment:
- Shares Allotted: 15,000 equity shares
- Face Value: ₹2 per share
- Plan: Employee Stock Option Plan-2005
- Approval Date: December 11, 2025
The allotment forms part of NIIT’s structured strategy to reward and retain employees by offering them equity participation in the company.
Listing and Compliance Process
NIIT Limited has initiated the necessary formalities to list these newly allotted shares on the stock exchanges. The company stated that it will soon file a listing application along with the required documentation to obtain approval for trading. Once cleared, the shares will be available for trading on both BSE and NSE.
Regulatory Filings and Communication
The company has formally informed both BSE Limited and the National Stock Exchange of India Limited about this development. NIIT trades under scrip code 500304 on BSE and symbol NIITLTD on NSE. The communication regarding the allotment was signed by Arpita Bisaria Malhotra, the Company Secretary and Compliance Officer.
The allotment reinforces NIIT’s ongoing commitment to its ESOP-2005 initiative, which has been a core part of its employee engagement and reward structure since its introduction.
Summary:
NIIT Limited has allotted 15,000 equity shares at a face value of ₹2 each under its Employee Stock Option Plan-2005. Approved on December 11, 2025, the company is now completing listing formalities and will soon seek trading approval from stock exchanges. The development was officially communicated to BSE and NSE, reflecting NIIT’s continued commitment to its long-running ESOP programme.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.